tiprankstipranks
Correction: Arcutis says no approval announcement made related to Zoryve sNDA
PremiumThe FlyCorrection: Arcutis says no approval announcement made related to Zoryve sNDA
12d ago
Arcutis supplemental new drug application for Zoryve approved by FDA, DSN says
PremiumThe Fly
Arcutis supplemental new drug application for Zoryve approved by FDA, DSN says
12d ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17d ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
PremiumPress Releases
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
3M ago
Arcutis Biotherapeutics Welcomes New CFO David Topper
PremiumCompany Announcements
Arcutis Biotherapeutics Welcomes New CFO David Topper
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100